In this episode of ATTD 2025 Conference Catch-Up, we dive into Beta Cell Therapies for Type 1 Diabetes, featuring innovative discussions on regenerative therapies, stem cell approaches, and novel treatments to protect and regenerate beta cells in the fight against Type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Human Beta Cell Regenerative Drug Therapy: A Journey from Impossible to Possible – Dr. Andrew Stewart Optimizing Differentiation and Engraftment of Stem Cell-Derived Islets for Type 1 Diabetes Treatment – Dr. Maria Cristina Nostro Optimizing Stem Cell-Derived Beta Cell Function for Transplantation – Prof. Matthias Hebrok Novel Type 1 Diabetes Therapies Targeting Endogenous Islet Cells – Prof. Anath Shalev This episode is an essential listen for endocrinologists, diabetes researchers, stem cell scientists, and healthcare professionals looking to stay on top of the latest advancements in beta cell regeneration and transplantation therapies for Type 1 diabetes. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related